Combining the TPVs detected through NGS and MLPA analyses (n = 74), most BRCA1/2 TPVs were detected in high-grade serous carcinoma (n = 67; 90.5%) (Supplementary Table S1). This evidence concerns the gene BRCA1 and serous adenocarcinoma.